The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Anticonvulsants in neuropathic pain: rationale and clinical evidence
Abstract
Neuropathic pain, whether of peripheral or central origin, is characterized by a neuronal hyperexcitability in damaged areas of the nervous system. In peripheral neuropathic pain, damaged nerve endings exhibit abnormal spontaneous and increased evoked activity, partly due to an increased and novel expression of sodium channels. In central pain, although not explored in detail, the spontaneous pain and evoked allodynia are also best explained by a neuronal hyperexcitability. The peripheral hyperexcitability is due to a series of molecular changes at the level of the peripheral nociceptor, in dorsal root ganglia, in the dorsal horn of the spinal cord, and in the brain. These changes include abnormal expression of sodium channels, increased activity at glutamate receptor sites, changes in γ‐aminobutyric acid (GABA‐ergic) inhibition, and an alteration of calcium influx into cells. The neuronal hyperexcitability and corresponding molecular changes in neuropathic pain have many features in common with the cellular changes in certain forms of epilepsy. This has led to the use of anticonvulsant drugs for the treatment of neuropathic pain. Carbamazepine and phenytoin were the first anticonvulsants to be used in controlled clinical trials. Studies have shown these agents to relieve painful diabetic neuropathy and paroxysmal attacks in trigeminal neuralgia. Subsequent studies have shown the anticonvulsant gabapentin to be effective in painful diabetic neuropathy, mixed neuropathies, and postherpetic neuralgia. Lamotrigine, a new anticonvulsant, is effective in trigeminal neuralgia, painful peripheral neuropathy, and post‐stroke pain. Other anticonvulsants, both new and old, are currently undergoing controlled clinical testing. The most common adverse effects of anticonvulsants are sedation and cerebellar symptoms (nystagmus, tremor and incoordination). Less common side‐effects include haematological changes and cardiac arrhythmia with phenytoin and carbamazepine. The introduction of a mechanism‐based classification of neuropathic pain, together with new anticonvulsants with a more specific pharmacological action, may lead to more rational treatment for the individual patient with neuropathic pain. © 2002 European Federation of Chapters of the International Association for the Study of Pain
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
Self-citationAnticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 713
An Evidence-Based Resource for Pain Relief
McQuay, H., & Moore, R. A. (1998) · Medical Entomology and Zoology · Cited by 569
Besson, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01313-6 · Cited by 450
Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F., & Sahagian, G. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1931 · Cited by 445
Zakrzewska, J. M., Chaudhry, Z., Nurmikko, T. J., Patton, D. W., & Mullens, L. E. (1997) · Pain · doi:10.1016/s0304-3959(97)00104-8 · Cited by 402
Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine
Leijon, G., & Boivie, J. (1989) · Pain · doi:10.1016/0304-3959(89)90108-5 · Cited by 392
Cited by
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Self-citationCation-Chloride Cotransporters and Neuronal Function
Blaesse, P., Airaksinen, M. S., Rivera, C., & Kaila, K. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.003 · Cited by 823
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
AAN-EFNS guidelines on trigeminal neuralgia management
Cruccu, G., Gronseth, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K., Nurmikko, T., & Zakrzewska, J. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02185.x · Cited by 726
Metadata
- Authors
- Jensen, T. S.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 6
- Issue
- SA
- Pages
- 61-68
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2002543001
- Cited by
- 305
- References
- 27
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anticonvulsants in neuropathic pain: rationale and clinical evidence. https://app.cochat.ai/papers/10.1053/eujp.2001.0324
- The paper
- Jensen, T. S. (2002). Anticonvulsants in neuropathic pain: rationale and clinical evidence. European Journal of Pain. https://doi.org/10.1053/eujp.2001.0324
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.